Detection of Renal Injury Following Primary Coronary Intervention among ST-Segment Elevation Myocardial Infarction Patients: Doubling the Incidence Using Neutrophil Gelatinase-Associated Lipocalin as a Renal Biomarker
Background: A subgroup of patients with acute kidney injury (AKI) do not fulfil the functional criteria for AKI diagnosis but show elevated levels of new biomarkers reflecting tubular injury, suggesting that these patients suffer “subclinical AKI”. We investigated the incidence and possible implicat...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/10/2120 |
_version_ | 1797534112130531328 |
---|---|
author | Lior Lupu Keren-Lee Rozenfeld David Zahler Samuel Morgan Ilan Merdler Moshe Shtark Ilana Goldiner Shmuel Banai Yacov Shacham |
author_facet | Lior Lupu Keren-Lee Rozenfeld David Zahler Samuel Morgan Ilan Merdler Moshe Shtark Ilana Goldiner Shmuel Banai Yacov Shacham |
author_sort | Lior Lupu |
collection | DOAJ |
description | Background: A subgroup of patients with acute kidney injury (AKI) do not fulfil the functional criteria for AKI diagnosis but show elevated levels of new biomarkers reflecting tubular injury, suggesting that these patients suffer “subclinical AKI”. We investigated the incidence and possible implications of “subclinical AKI”, compared to no and clinical AKI among ST elevation myocardial infarction patients (STEMI) treated with primary coronary intervention (PCI). Methods: We included 223 patients with STEMI treated with PCI. Neutrophil gelatinase-associated lipocalin (NGAL) was used as a marker of renal tubular damage in the absence of functional AKI, with NGAL levels ≥100 ng/mL suggesting subclinical AKI. Patients were assessed for the occurrence of in-hospital adverse outcomes. Results: Of the study patients, 45 (25%) had subclinical AKI. These patients were more likely to have left ventricular ejection fraction ≤45% (33% vs. 23%. <i>p</i> = 0.01), in-hospital adverse outcomes (73% vs. 48%; <i>p</i> = 0.005), and a combination of the two. The multivariate regression model demonstrated that subclinical AKI was independently associated with in-hospital adverse outcomes (OR 3.71, 95% CI 1.30–10.62, <i>p</i> = 0.02). Conclusions: Subclinical AKI is common among STEMI patients and is independently associated with adverse outcomes, even in the absence of functional AKI. |
first_indexed | 2024-03-10T11:25:01Z |
format | Article |
id | doaj.art-96174b6a9cf7426782a2080af8eecf33 |
institution | Directory Open Access Journal |
issn | 2077-0383 |
language | English |
last_indexed | 2024-03-10T11:25:01Z |
publishDate | 2021-05-01 |
publisher | MDPI AG |
record_format | Article |
series | Journal of Clinical Medicine |
spelling | doaj.art-96174b6a9cf7426782a2080af8eecf332023-11-21T19:43:18ZengMDPI AGJournal of Clinical Medicine2077-03832021-05-011010212010.3390/jcm10102120Detection of Renal Injury Following Primary Coronary Intervention among ST-Segment Elevation Myocardial Infarction Patients: Doubling the Incidence Using Neutrophil Gelatinase-Associated Lipocalin as a Renal BiomarkerLior Lupu0Keren-Lee Rozenfeld1David Zahler2Samuel Morgan3Ilan Merdler4Moshe Shtark5Ilana Goldiner6Shmuel Banai7Yacov Shacham8Department of Cardiology, Tel-Aviv Sourasky Medical Center affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 64239, IsraelDepartment of Cardiology, Tel-Aviv Sourasky Medical Center affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 64239, IsraelDepartment of Cardiology, Tel-Aviv Sourasky Medical Center affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 64239, IsraelDepartment of Cardiology, Tel-Aviv Sourasky Medical Center affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 64239, IsraelDepartment of Cardiology, Tel-Aviv Sourasky Medical Center affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 64239, IsraelDepartment of Cardiology, Tel-Aviv Sourasky Medical Center affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 64239, IsraelDepartment of Cardiology, Tel-Aviv Sourasky Medical Center affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 64239, IsraelDepartment of Cardiology, Tel-Aviv Sourasky Medical Center affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 64239, IsraelDepartment of Cardiology, Tel-Aviv Sourasky Medical Center affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 64239, IsraelBackground: A subgroup of patients with acute kidney injury (AKI) do not fulfil the functional criteria for AKI diagnosis but show elevated levels of new biomarkers reflecting tubular injury, suggesting that these patients suffer “subclinical AKI”. We investigated the incidence and possible implications of “subclinical AKI”, compared to no and clinical AKI among ST elevation myocardial infarction patients (STEMI) treated with primary coronary intervention (PCI). Methods: We included 223 patients with STEMI treated with PCI. Neutrophil gelatinase-associated lipocalin (NGAL) was used as a marker of renal tubular damage in the absence of functional AKI, with NGAL levels ≥100 ng/mL suggesting subclinical AKI. Patients were assessed for the occurrence of in-hospital adverse outcomes. Results: Of the study patients, 45 (25%) had subclinical AKI. These patients were more likely to have left ventricular ejection fraction ≤45% (33% vs. 23%. <i>p</i> = 0.01), in-hospital adverse outcomes (73% vs. 48%; <i>p</i> = 0.005), and a combination of the two. The multivariate regression model demonstrated that subclinical AKI was independently associated with in-hospital adverse outcomes (OR 3.71, 95% CI 1.30–10.62, <i>p</i> = 0.02). Conclusions: Subclinical AKI is common among STEMI patients and is independently associated with adverse outcomes, even in the absence of functional AKI.https://www.mdpi.com/2077-0383/10/10/2120neutrophil gelatinase-associated lipocalinST-segment elevation myocardial infarctionrenal injury |
spellingShingle | Lior Lupu Keren-Lee Rozenfeld David Zahler Samuel Morgan Ilan Merdler Moshe Shtark Ilana Goldiner Shmuel Banai Yacov Shacham Detection of Renal Injury Following Primary Coronary Intervention among ST-Segment Elevation Myocardial Infarction Patients: Doubling the Incidence Using Neutrophil Gelatinase-Associated Lipocalin as a Renal Biomarker Journal of Clinical Medicine neutrophil gelatinase-associated lipocalin ST-segment elevation myocardial infarction renal injury |
title | Detection of Renal Injury Following Primary Coronary Intervention among ST-Segment Elevation Myocardial Infarction Patients: Doubling the Incidence Using Neutrophil Gelatinase-Associated Lipocalin as a Renal Biomarker |
title_full | Detection of Renal Injury Following Primary Coronary Intervention among ST-Segment Elevation Myocardial Infarction Patients: Doubling the Incidence Using Neutrophil Gelatinase-Associated Lipocalin as a Renal Biomarker |
title_fullStr | Detection of Renal Injury Following Primary Coronary Intervention among ST-Segment Elevation Myocardial Infarction Patients: Doubling the Incidence Using Neutrophil Gelatinase-Associated Lipocalin as a Renal Biomarker |
title_full_unstemmed | Detection of Renal Injury Following Primary Coronary Intervention among ST-Segment Elevation Myocardial Infarction Patients: Doubling the Incidence Using Neutrophil Gelatinase-Associated Lipocalin as a Renal Biomarker |
title_short | Detection of Renal Injury Following Primary Coronary Intervention among ST-Segment Elevation Myocardial Infarction Patients: Doubling the Incidence Using Neutrophil Gelatinase-Associated Lipocalin as a Renal Biomarker |
title_sort | detection of renal injury following primary coronary intervention among st segment elevation myocardial infarction patients doubling the incidence using neutrophil gelatinase associated lipocalin as a renal biomarker |
topic | neutrophil gelatinase-associated lipocalin ST-segment elevation myocardial infarction renal injury |
url | https://www.mdpi.com/2077-0383/10/10/2120 |
work_keys_str_mv | AT liorlupu detectionofrenalinjuryfollowingprimarycoronaryinterventionamongstsegmentelevationmyocardialinfarctionpatientsdoublingtheincidenceusingneutrophilgelatinaseassociatedlipocalinasarenalbiomarker AT kerenleerozenfeld detectionofrenalinjuryfollowingprimarycoronaryinterventionamongstsegmentelevationmyocardialinfarctionpatientsdoublingtheincidenceusingneutrophilgelatinaseassociatedlipocalinasarenalbiomarker AT davidzahler detectionofrenalinjuryfollowingprimarycoronaryinterventionamongstsegmentelevationmyocardialinfarctionpatientsdoublingtheincidenceusingneutrophilgelatinaseassociatedlipocalinasarenalbiomarker AT samuelmorgan detectionofrenalinjuryfollowingprimarycoronaryinterventionamongstsegmentelevationmyocardialinfarctionpatientsdoublingtheincidenceusingneutrophilgelatinaseassociatedlipocalinasarenalbiomarker AT ilanmerdler detectionofrenalinjuryfollowingprimarycoronaryinterventionamongstsegmentelevationmyocardialinfarctionpatientsdoublingtheincidenceusingneutrophilgelatinaseassociatedlipocalinasarenalbiomarker AT mosheshtark detectionofrenalinjuryfollowingprimarycoronaryinterventionamongstsegmentelevationmyocardialinfarctionpatientsdoublingtheincidenceusingneutrophilgelatinaseassociatedlipocalinasarenalbiomarker AT ilanagoldiner detectionofrenalinjuryfollowingprimarycoronaryinterventionamongstsegmentelevationmyocardialinfarctionpatientsdoublingtheincidenceusingneutrophilgelatinaseassociatedlipocalinasarenalbiomarker AT shmuelbanai detectionofrenalinjuryfollowingprimarycoronaryinterventionamongstsegmentelevationmyocardialinfarctionpatientsdoublingtheincidenceusingneutrophilgelatinaseassociatedlipocalinasarenalbiomarker AT yacovshacham detectionofrenalinjuryfollowingprimarycoronaryinterventionamongstsegmentelevationmyocardialinfarctionpatientsdoublingtheincidenceusingneutrophilgelatinaseassociatedlipocalinasarenalbiomarker |